Natural Health News

Meetings being held between the National Academy of Sciences (NAS) and other world bodies to discuss “harmonization” (meaning restriction) of “nutrient intake” recommendations indicate that the answer may be yes.  Action Alert! NAS, which is a United States non-governmental organization that advises the federal government on a range of issues, recently met with groups from […]

Bribery. Action Alert! Separate reports have surfaced that demonstrate both doctors and politicians are on opioid-makers’ pay roll. In return, it appears as though doctors have prescribed more opioids and lawmakers have backed legislation to make it harder to combat the opioid crisis. This is cronyism 101. First, the doctors. Researchers have reported evidence that […]

Thanks to ANH member activism over many years, Congress has finally approved Right to Try legislation. Now we need to expand it. Action Alert! Recently, the House of Representatives approved legislation that expands access to experimental drugs for terminally ill patients who have exhausted all other treatment options. It also frees drug companies from liability where […]

ANH members played a key role in thwarting efforts to eliminate access to personalized medicine. Two years ago, the FDA released a draft guidance saying that a compounding pharmacy (a pharmacy that makes customized medicines for individual patients) cannot register as both an “outsourcing” (503B) and a traditional (503A) facility. We issued an action alert […]

Consumers Down Under will have access to more information about alternative medicines. A bill was recently approved in Australia that loosens some of the regulations governing advertising claims made by producers of alternative and complementary products. The Therapeutic Goods Amendment Bill 2017 creates a list of “permitted indications” which can be used in advertising without […]

One person’s health care crisis is Big Pharma’s golden opportunity. From Stat News: The White House’s national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its use. Federal […]